Fact CheckerSign in

NCT06038188Completed

Remote 3-week Booster Intervention to Reduce Sedentary Time in Patients With Coronary Artey Disease

Effectiveness of a Remote 3-week Booster Intervention to Reduce Sedentary Time in Patients With Coronary Artey Disease: a Randomized Clinical Trial.

Source: ClinicalTrials.gov · Last updated 28 Mar 2024

Brief summary (registry, in English)

The goal of this clinical trial is to learn about the effect of a booster program aiming to lower daily sitting time (SIT LESS Booster program) compared to usual care in patient with coronary heart problems. The main question it aims to answer is: What is the effect of the SIT LESS Booster on sedentary time and physical activity levels in patient with coronary artery disease who participated in cardiac rehabilitation. Participants will be randomized into 2 groups: 1. Control group who receives usual care; 2. SIT LESS Booster group who receives usual care + a remote 3-week SIT LESS Booster program. Objectively measured changes in daily sitting time from pre- to post SIT LESS Booster will be compared between groups to see if participants in the SIT LESS Booster group are able to reduce daily sedentary time more compared to participants in the control group.

Status (registry)
Completed
Study type
Interventional
Enrollment
48 (actual)
First submitted
30 Aug 2023
Start date
30 Aug 2023
Primary completion date
31 Dec 2023
Lead sponsor
Radboud University Medical Center
NCT number
NCT06038188

What you commit to

  • Study type: Interventional
  • Participants enrolled: 48
  • From 30 Aug 2023 to the primary completion date, 31 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Coronary arterial bypass graft surgery expected within 8 weeks after inclusion

Other illness

  • New York Heart Association class III or IV heart failure

Other

  • Unable to give informed consent
  • Wheelchair-bounded / not physically able to stand or walk.
  • Language barrier
  • Participation in another interventional study targeting SB or PA

Who the study is looking for

  • Participation in the SIT LESS intervention group of the SIT LESS study

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Radboudumc
Coordinator of this site? Confirm its status
NijmegenNetherlandsUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.